Literature DB >> 28879449

Prognostic factors of mortality in Iranian patients with systemic lupus erythematosus admitted to intensive care unit.

Alimohammad Fatemi1, Somayeh Shamsaee2, Ahmad Raeisi2, Zahra Sayedbonakdar3, Abbas Smiley4.   

Abstract

The aim was to determine the course, outcome, and determinants of mortality in patients with systemic lupus erythematosus (SLE) in intensive care unit (ICU). SLE patients admitted to ICU from 2004 to 2015 were recruited retrospectively. Demographic data, disease characteristics, causes of admission, baseline SLE disease activity index-2K (SLEDAI-2K) and Acute Physiologic and Chronic Health Evaluation II (APACHE) score, the outcome, and the causes of death were recorded. Predictors of mortality were compared between alive and dead patients by Cox regression analysis. Ninety-four patients with SLE were enrolled. Mean age at the time of ICU admission was 29.6 years. Average scores of SLEDAI and APACHE II were 11.3 and 19.8, respectively. The most common causes of ICU admission were pneumonia, diffuse alveolar hemorrhage (DAH), and seizure. Forty-seven patients (50%) died in ICU. The principal causes of death were septic shock (25.5%), multi-organ failure (12.5%), DAH (10.6%), and pneumonia (10.6%). After multivariate analysis, high APACHE II, septic shock, and duration of mechanical ventilation were indicators of survival outcome. Mean (95% CI) survival days in ICU in patients with and without respiratory failure were 14.6 (10.4-18.9) and 28.7 (17.9-39.5) days, respectively (P = 0.001). This figure for those with and without septic shock was 13.5 (4.9-11.1) and 22.3 (9.3-24.7) days, respectively (P = 0.016). High APACHE II, septic shock, and duration of mechanical ventilation were the main predictors of death in patients with SLE in ICU. Multicenter studies are needed to draw a fine picture of SLE behavior in ICU.

Entities:  

Keywords:  Intensive care unit; Mortality; Outcome; Systemic lupus erythematosus

Mesh:

Year:  2017        PMID: 28879449     DOI: 10.1007/s10067-017-3808-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit.

Authors:  Javier A Cavallasca; María Del Rosario Maliandi; Sergio Sarquis; Maria Betina Nishishinya; Alejandra Schvartz; Abelardo Capdevila; Gustavo G Nasswetter
Journal:  J Clin Rheumatol       Date:  2010-12       Impact factor: 3.517

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

4.  Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

Authors:  D A Whitelaw; R Gopal; V Freeman
Journal:  Clin Rheumatol       Date:  2004-11-25       Impact factor: 2.980

5.  Expectations and outcomes of prolonged mechanical ventilation.

Authors:  Christopher E Cox; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice L Gray; Maren K Olsen; Joseph A Govert; Shannon S Carson; James A Tulsky
Journal:  Crit Care Med       Date:  2009-11       Impact factor: 7.598

6.  Outcome of patients with systemic lupus erythematosus in intensive care unit.

Authors:  A H Alzeer; A Al-Arfaj; S J Basha; S Alballa; J Al-Wakeel; H Al-Arfaj; S Al-Sugair; S Al-Mugeiren; M Al-Shamairi; E A Bamgboye
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.

Authors:  Frances Rees; Michael Doherty; Matthew J Grainge; Peter Lanyon; Graham Davenport; Weiya Zhang
Journal:  Rheumatology (Oxford)       Date:  2016-01-08       Impact factor: 7.580

8.  Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit.

Authors:  S A Namendys-Silva; J A Baltazar-Torres; E Rivero-Sigarroa; J A Fonseca-Lazcano; L Montiel-López; G Domínguez-Cherit
Journal:  Lupus       Date:  2009-10-22       Impact factor: 2.911

9.  Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit.

Authors:  B K Han; R Bhatia; P Traisak; K Hunter; B Milcarek; C Schorr; H Eid; D Feinstein; P Cronin; S L Kolasinski
Journal:  Lupus       Date:  2013-05-20       Impact factor: 2.911

10.  All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre.

Authors:  June Lee; Nimrit Dhillon; Janet Pope
Journal:  Rheumatology (Oxford)       Date:  2013-01-09       Impact factor: 7.580

View more
  4 in total

1.  Short- and long-term prognosis of acute critically ill patients with systemic rheumatic diseases: A retrospective multicentre study.

Authors:  Paul Chabert; William Danjou; Mehdi Mezidi; Julien Berthiller; Audrey Bestion; Abla-Akpene Fred; Claude Guerin; Laurent Argaud; Vincent Piriou; Eric Bonnefoy-Cudraz; Jean-Jacques Lehot; Jean-Luc Fellahi; Thomas Rimmele; Frederic Aubrun; Jean-Christophe Richard; Laure Gallay; Arnaud Hot
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

Review 2.  Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know.

Authors:  Mohanned Mustafa; Easwaradhas Gladston Chelliah; Michael Hughes
Journal:  Rheumatol Int       Date:  2018-03-16       Impact factor: 2.631

3.  In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002-2017.

Authors:  Marwan H Adwan; Ula Qasem; Khader N Mustafa
Journal:  Rheumatol Int       Date:  2020-03-07       Impact factor: 2.631

4.  Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran.

Authors:  Mojgan Arjmand; Reza Shahriarirad; Saeedeh Shenavandeh; Mohammad Javad Fallahi
Journal:  Clin Rheumatol       Date:  2022-08-15       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.